We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Oilex Ld | LSE:OEX | London | Ordinary Share | AU000000OEX8 | ORD NPV |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.165 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMOEX
RNS Number : 9812A
Oilex Ltd
17 September 2018
ASX Announcement
17 September 2018
ASX: OEX
AIM: OEX
Re: Issue of Securities and Capital Raising Amendment
Oilex Ltd (the Company) is pleased to advise that it has issued today the first tranche of 157,894,737 shares to the clients of Novum Securities Ltd (Novum) pursuant to the capital raising announced on 11 September 2018 (Placement).
On 11 September 2018, the Company announced a debt and equity capital raising of GBP0.63 million (A$1.14 million) including the issue of 157,894,737 shares at 0.19 pence for GBP300,000 to clients of Novum (Novum Shares). The issue of the remaining shares together with the drawdown of the loans pursuant to the Placement are anticipated to be completed on or about the end of this month.
Pursuant to the advisory agreement with Novum, the Company has today also issued 9,473,684 million options exercisable at 0.19 pence on before 17 September 2021 (Novum Options).
The issue of above mentioned Novum Shares under LR7.1A and Novum Options under LR7.1 are included in the attached Appendix 3B.
Issue of Series A Loan Options
On 26 July 2018 and 15 August 2018, the Company announced that it had entered into $330,000 in loan agreements (A Series Loans). Pursuant to Series A Loan agreements, following the approval of shareholders on 14 September 2018, the Company has today issued 91,666,666 options exercisable at A$0.0036 on or before 26 July 2019 (Series A Loan Options).
The issue of 83,333,333 Series A Loan Options is pursuant to LR7.1 shareholder approval with the balance of 8,333,333 options issued under the Company's LR 7.1 capacity. The issue of the Series A Loan Options is included in the attached Appendix 3B.
Capital Raising Amendment
The Company advises that Placement announced on 11 September 2018 has been amended from GBP0.63 million to GBP0.70 million (A$1.27 million). The amendment comprises:
-- an increase in the loans from A$250,000 to A$315,000 together with a further 15,772,871 options (expiry date of 1 October 2019, exercise price of $0.4121) on the same terms and conditions; and
-- an increase of proposed share issue of GBP35,000, being an increase 18,421,053 shares at 0.19 pence.
The abovementioned new agreements are not with related parties of the Company. Funds raised from the Placement are intended to be applied to the working capital requirements of the Company. The issue of the additional shares and loan options are subject to shareholder approval under LR7.1, if required. Settlement for the additional loan funding and equity proceeds is anticipated to be on or about 30 September 2018 with the applicable Appendix 3B to be released at that time.
Issue of Consultant Shares
The Company advises that it has entered into an agreement for consultancy services with 10,526,315 shares to be issued at GBP0.0019 per share as consideration in lieu of fees. The consultancy agreement is not with a related party with the shares to be issued pursuant under LR7.1 on or about 30 September 2018, the applicable Appendix 3B will be released at that time.
Section 708A(5)(e) Statement
Pursuant to the issue of the abovementioned Novum Shares, Novum Options and the Series A Loan Options, Oilex gives notice under section 708A(5)(e) of the Corporations Act (Cth) (Act) that:
1) Oilex issued the Shares without disclosure to investors under Part 6D.2 of the Act; 2) As at the date of this notice, Oilex has complied with: a) the provisions of Chapter 2M of the Act as they apply to Oilex; and b) section 674 of the Act; and
3) As at the date of this notice, there is no information that is 'excluded information' within the meaning of sections 708A(7) and 708(8) of the Act.
For and on behalf of Oilex Ltd
Mark Bolton
Chief Financial Officer Company Secretary
For further information, please contact:
Hot Features
Premium
Investor AIM Broker AIM Nominated Media Enquires Media Enquiries
Enquiries Cornhill Capital Adviser (UK) (Aus)
Oilex Ltd Limited Strand Hanson Vigo Citadel-MAGNUS
Joe Salomon Broker Limited Communications Michael Weir
Managing Daniel Gee Nominated Adviser Public Relations Email:
Director Email: Rory Murphy/Ritchie Patrick mweir@citadelmagnus.
Email: danielg@cornhillcapital. Balmer d'Ancona/Chris com
oilex@oilex. com Email: McMahon Tel: +618
com.au oilex@strandhanson. Email: 6160 4900
Tel: +61 Tel: +44 20 co.uk patrick.dancona@vi Australia
8 9485 3200 3700 2500 Tel: +44 20 gocomms.com
Australia UK 7409 3494 chris.mcmahon@vigo
UK comms.com
Tel:+ 44 20 7390
0230
UK
Rule 2.7, 3.10.3, 3.10.4, 3.10.5
Appendix 3B
New issue announcement,
application for quotation of additional securities
and agreement
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13
Name of entity OILEX LTD ABN 50 078 652 632
We (the entity) give ASX the following information.
Part 1 -- All issues
You must complete the relevant sections (attach sheets if there is not enough space).
1 +Class of +securities issued (a) Fully Paid Ordinary Shares
or to be issued (b) Unlisted options
(c) Unlisted options
(d) Unlisted options
2 Number of +securities issued (a) 157,894,737 shares to clients
or to be issued (if known) of Novum (LR7.1A)
or maximum number which may (b) 9,473,684 options (LR7.1)
be issued (c) 8,333,333 Series A Loan
Options (LR7.1)
(d) 83,333,333 Series A Loan
Options (LR7.1)
3 Principal terms of the +securities (a) Fully Paid Ordinary Shares
(eg, if options, exercise (b) Options (GBP0.0019, 17
price and expiry date; if September 2021)
partly paid +securities, (c) Options (A$0.0036, 26 July
the amount outstanding and 2019)
due dates for payment; if (d) Options (A$0.0036, 26 July
+convertible securities, 2019)
the conversion price and
dates for conversion)
4 Do the (+) securities rank a) Yes
equally in all respects b,c and d) No, new class of option
from the date of allotment security. Rank equally upon conversion.
with an existing +class No right to participate in dividends.
of quoted +securities?
If the additional securities
do not rank equally, please
state:
* the date from which they do
* the extent to which they participate for the next
dividend, (in the case of a trust, distribution) or
interest payment
* the extent to which they do not rank equally, other
than in relation to the next dividend, distribution
or interest payment
5 Issue price or consideration (a) GBP0.0019 per share (GBP300,000
in total)
(b) Nil
(c) Nil
(d) Nil
-------------------------------------------------
6 Purpose of the issue (a) Proceeds from the issue of
(If issued as consideration 157,894,737 shares will be applied
for the acquisition of towards ongoing working capital
assets, clearly identify requirements
those assets) (b) Part consideration for advisory
fees pursuant to capital raising.
(c) Part consideration for provision
of loan facility.
(d) Part consideration for provision
of loan facility.
-------------------------------------------------
6a Is the entity an (+) eligible
entity that has obtained Yes
security holder approval
under rule 7.1A?
If Yes, complete sections
6b - 6h in relation to
the +securities the subject
of this Appendix 3B, and
comply with section 6i
-------------------------------------------------
6b The date the security holder
resolution under rule 7.1A 29 November 2017
was passed
-------------------------------------------------
6c Number of (+) securities 17,807,017 comprising (b) and
issued without security (c)
holder approval under rule
7.1
-------------------------------------------------
Number of (+) securities
issued with security holder
6d approval under rule 7.1A 157,894,737 (a)
-------------------------------------------------
6e Number of +securities issued 83,333,333 options (d)
with security holder approval
under rule 7.3, or another
specific security holder
approval (specify date
of meeting)
-------------------------------------------------
6f Number of (+) securities Not applicable
issued under an exception
in rule 7.2
-------------------------------------------------
6g If (+) securities issued Yes
under rule 7.1A was issue 15 day VWAP as at COB 11/09/2018
price at least 75% of 15 = A$0.003124
day VWAP as calculated 75% of VWAP = A$0.002343
under rule 7.1A.3? Include Issue price - GBP0.0019 (A$0.3434)
the (+) issue date and Data provided by licensed stock
both values. Include the broker
source of the VWAP calculation.
-------------------------------------------------
6h If (+) securities were issued Not applicable
under rule 7.1A for non-cash
consideration, state date
on which valuation of
consideration
was released to ASX Market
Announcements
6i Calculate the entity's remaining Listing Rule 7.1: 282,488,239
issue capacity under rule 7.1 Listing Rule 7.1A: 42,302,100
and rule 7.1A - complete Annexure
1 and release to ASX Market
Announcements
7 (+) Issue dates 17 September 2018
Notes: The issue date may be
prescribed by ASX (refer to
the definition of issue date
in rule 19.12). For example,
the issue date for a pro rata
entitlement issue must comply
with the applicable timetable
in appendix 7A.
Cross reference: item 33 of
Appendix 3B.
------------------------------------------------------------------------------------
8 Number and +class of all +securities Number (+) Class
quoted on ASX (including the
(+) securities in section 2
if applicable)
---------------------------------
2,159,863,116 Fully Paid Ordinary
Shares
--------------------------------- -------------------------------------------------
9 Number and +class of all +securities Number +Class
not quoted on ASX (including
the securities in section 2
if applicable)
---------------------------------
77,166,666 GBP0.00225 Options
(22/05/2020)
91,666,666 $0.0034 Options (1/10/2019)
9,473,684 GBP0.0019 Options
(1/10/2021)
--------------------------------- -------------------------------------------------
10 Dividend policy (in the case Not applicable
of a trust, distribution policy)
on the increased capital (interests)
------------------------------------------------------------------------------------
Part 2 -- Pro rata issue
11 Is security holder approval Not applicable
required?
12 Is the issue renounceable
or non-renounceable?
13 Ratio in which the +securities
will be offered
14 +Class of +securities
to which the offer relates
15 +Record date to determine
entitlements
16 Will holdings on different
registers (or subregisters)
be aggregated for calculating
entitlements?
17 Policy for deciding entitlements
in relation to fractions
18 Names of countries in
which the entity has
security holders who
will not be sent new
issue documents
Note: Security holders
must be told how their
entitlements are to be
dealt with.
Cross reference: rule
7.7.
19 Closing date for receipt
of acceptances or renunciations
20 Names of any underwriters
21 Amount of any underwriting
fee or commission
22 Names of any brokers
to the issue
23 Fee or commission payable
to the broker to the
issue
24 Amount of any handling
fee payable to brokers
who lodge acceptances or
renunciations on behalf
of security holders
25 If the issue is contingent
on security holders' approval,
the date of the meeting
26 Date entitlement and acceptance
form and offer documents
will be sent to persons
entitled
27 If the entity has issued
options, and the terms
entitle option holders
to participate on exercise,
the date on which notices
will be sent to option
holders
28 Date rights trading will
begin (if applicable)
29 Date rights trading will
end (if applicable)
30 How do security holders
sell their entitlements
in full through a broker?
31 How do security holders
sell part of their entitlements
through a broker and accept
for the balance?
32 How do security holders
dispose of their entitlements
(except by sale through
a broker)?
33 +Issue date
Part 3 -- Quotation of securities
You need only complete this section if you are applying for quotation of securities
34 Type of securities
(tick one)
(a) ü (+) Securities described in Part 1
(b) o All other (+) securities
Example: restricted securities at the end of the
escrowed period, partly paid securities that become
fully paid, employee incentive share securities
when restriction ends, securities issued on expiry
or conversion of convertible securities
Entities that have ticked box 34(a)
Additional securities forming a new class of securities
Tick to indicate you are providing the information or
documents
35 If the +securities are +equity securities, the names
of the 20 largest holders of the additional +securities,
and the number and percentage of additional +securities
held by those holders
36 If the +securities are +equity securities, a distribution
schedule of the additional +securities setting out
the number of holders in the categories
1 - 1,000
1,001 - 5,000
5,001 - 10,000
10,001 - 100,000
100,001 and over
37 A copy of any trust deed for the additional +securities
Entities that have ticked box 34(b)
38 Number of securities
for which +quotation
is sought
39 +Class of +securities
for which quotation is
sought
----
40 Do the +securities rank
equally in all respects
from the +issue date
with an existing +class
of quoted +securities?
If the additional +securities
do not rank equally,
please state:
* the date from which they do
* the extent to which they participate for the next
dividend, (in the case of a trust, distribution) or
interest payment
* the extent to which they do not rank equally, other
than in relation to the next dividend, distribution
or interest payment
----
41 Reason for request for
quotation now
Example: In the case
of restricted securities,
end of restriction period
(if issued upon conversion
of another (+) security,
clearly identify that
other (+) security)
----
42 Number and +class of all +securities Number (+) Class
quoted on ASX (including the
securities in clause 38)
-------
Quotation agreement
1 +Quotation of our additional +securities is in ASX's absolute discretion. ASX may quote the +securities on any conditions it decides.
2 We warrant the following to ASX.
-- The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.
-- There is no reason why those +securities should not be granted +quotation.
-- An offer of the +securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.
Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty
-- Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.
-- If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.
3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.
4 We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.
Mark Bolton
Company Secretary
Date: 17 September 2018
Appendix 3B - Annexure 1
Calculation of placement capacity under rule 7.1 and rule 7.1A for (+) eligible entities
Introduced 01/08/12, Amended 04/03/13
Part 1
Rule 7.1 - Issues exceeding 15% of capital
Step 1: Calculate "A", the base figure from which the placement
capacity is calculated
Insert number of fully paid
(+) ordinary securities on
issue 12 months before the
(+) issue date or date of
agreement to issue 1,698,112,165
------------------------------------------------------
Add the following:
* Number of fully paid (+) ordinary securities issued Nil
in that 12 month period under an exception in rule
7.2
------------------------------------------------------
15,430,833 shares (Issued 12/12/2017)
* Number of fully paid (+) ordinary securities issued 157,894,737 shares (issued 29/01/2018)
in that 12 month period with shareholder approval 2,759,844 shares (issued 01/03/2018)
2,770,800 shares (issued 15/5/2018)
125,000,000 shares (Issued 15/5/2018)
------------------------------------------------------
Nil
* Number of partly paid (+) ordinary securities that
became fully paid in that 12 month period
------------------------------------------------------
Note:
* Include only ordinary securities here - other classes
of equity securities cannot be added
* Include here (if applicable) the securities the
subject of the Appendix 3B to which this form is
annexed
* It may be useful to set out issues of securities on
different dates as separate line items
------------------------------------------------------
Subtract the number of fully Nil
paid (+) ordinary securities
cancelled during that 12
month period
------------------------------------------------------
"A" 2,001,968,379
------------------------------------------------------
Step 2: Calculate 15% of "A"
"B" 0.15
[Note: this value cannot be
changed]
-------------------------------------------
Multiply "A" by 0.15 300,295,256
-------------------------------------------
Step 3: Calculate "C", the amount of placement capacity
under rule 7.1 that has already been used
Insert number of (+) equity
securities issued or agreed 9,473,684 options
to be issued in that 12 (17/9/2018)
month period not counting 8,333,333 options
those issued: (17/9/2018)
* Under an exception in rule 7.2
* Under rule 7.1A
* With security holder approval under rule 7.1 or rule
7.4
Note:
* This applies to equity securities, unless
specifically excluded - not just ordinary securities
* Include here (if applicable) the securities the
subject of the Appendix 3B to which this form is
annexed
* It may be useful to set out issues of securities on
different dates as separate line items
-------------------------------------------
"C" 17,807,017
-------------------------------------------
Step 4: Subtract "C" from ["A" x "B"] to calculate remaining
placement capacity under rule 7.1
"A" x 0.15
Note: number must be same
as shown in Step 2 300,295,256
-------------------------------------------
Subtract "C"
Note: number must be same
as shown in Step 3 17,807,017
-------------------------------------------
Total ["A" x 0.15] - "C" 282,488,239
[Note: this is the remaining
placement
capacity under rule 7.1]
-------------------------------------------
Part 2
Rule 7.1A - Additional placement capacity for eligible entities
Step 1: Calculate "A", the base figure from which the placement
capacity is calculated
"A"
Note: number must be same
as shown in Step 1 of Part
1 2,001,968,379
------------------------------------------
Step 2: Calculate 10% of "A"
"D" 0.10
Note: this value cannot be
changed
------------------------------------------
Multiply "A" by 0.10 200,196,837
------------------------------------------
Step 3: Calculate "E", the amount of placement capacity under
rule 7.1A that has already been used
Insert number of equity securities
issued or agreed to be issued 157,894,737 shares
in that 12 month period under (17/9/2018)
rule 7.1A
Notes:
* This applies to equity securities - not just ordinary
securities
* Include here - if applicable - the securities the
subject of the Appendix 3B to which this form is
annexed
* Do not include equity securities issued under rule
7.1 (they must be dealt with in Part 1), or for which
specific security holder approval has been obtained
* It may be useful to set out issues of securities on
different dates as separate line items
------------------------------------------
"E" -
------------------------------------------
Step 4: Subtract "E" from ["A" x "D"] to calculate remaining
placement capacity under rule 7.1A
"A" x 0.10
Note: number must be same
as shown in Step 2 42,302,100
------------------------------------------
Subtract "E" -
Note: number must be same
as shown in Step 3
------------------------------------------
Total ["A" x 0.10] - "E" 42,302,100
Note: this is the remaining
placement
capacity under rule 7.1A
------------------------------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
MSCGGUGWBUPRGUM
(END) Dow Jones Newswires
September 17, 2018 06:38 ET (10:38 GMT)
1 Year Oilex Ld Chart |
1 Month Oilex Ld Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
